Valuation Asymchem Laboratories (Tianjin) Co., Ltd. Hong Kong S.E.
Stocks
6821
CNE100004Z06
Pharmaceuticals
|
Market Closed -
Hong Kong S.E.
04:08:55 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 134.20 HKD | -2.82% |
|
+0.30% | +88.48% |
Company Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,228 | 52,704 | 41,387 | 26,238 | 32,605 | 57,653 | - | - |
| Change | - | -52.62% | -21.47% | -36.6% | 24.27% | 76.82% | - | - |
| Enterprise Value (EV) 1 | 105,383 | 47,524 | 34,318 | 20,491 | 26,337 | 52,979 | 53,997 | 54,796 |
| Change | - | -54.9% | -27.79% | -40.29% | 28.53% | 101.16% | 1.92% | 1.48% |
| P/E | 99.1x | 16.4x | 18.5x | 28.3x | 29.4x | 43.7x | 33x | 27.2x |
| PBR | 9.07x | 3.5x | 2.46x | 1.66x | 1.9x | 3.16x | 2.95x | 2.72x |
| PEG | - | 0x | -0.6x | -0.5x | 1.7x | 2.3x | 1x | 1.3x |
| Capitalization / Revenue | 24x | 5.15x | 5.29x | 4.52x | 4.89x | 7.13x | 5.88x | 4.86x |
| EV / Revenue | 22.7x | 4.65x | 4.39x | 3.53x | 3.95x | 6.55x | 5.51x | 4.62x |
| EV / EBITDA | 75.3x | 13.6x | 11.2x | 16.1x | 15.1x | 24.1x | 19.6x | 16.7x |
| EV / EBIT | 88.4x | 15.2x | 13.3x | 19x | 22.5x | 32.8x | 26.8x | 22.7x |
| EV / FCF | -68.1x | 41.8x | 14.6x | 164x | 192x | -107x | 64.9x | 41.3x |
| FCF Yield | -1.47% | 2.39% | 6.84% | 0.61% | 0.52% | -0.93% | 1.54% | 2.42% |
| Dividend per Share 2 | 0.5714 | 1.8 | 1.8 | 1.1 | 1.3 | 1.353 | 1.808 | 2.133 |
| Rate of return | 0.18% | 1.22% | 1.55% | 1.45% | 1.4% | 0.82% | 1.1% | 1.3% |
| EPS 2 | 3.136 | 9 | 6.26 | 2.69 | 3.16 | 3.754 | 4.979 | 6.042 |
| Distribution rate | 18.2% | 20% | 28.8% | 40.9% | 41.1% | 36% | 36.3% | 35.3% |
| Net sales 1 | 4,639 | 10,230 | 7,825 | 5,805 | 6,670 | 8,089 | 9,803 | 11,873 |
| EBITDA 1 | 1,399 | 3,498 | 3,058 | 1,274 | 1,744 | 2,199 | 2,750 | 3,284 |
| EBIT 1 | 1,192 | 3,136 | 2,571 | 1,079 | 1,169 | 1,615 | 2,018 | 2,413 |
| Net income 1 | 1,069 | 3,302 | 2,269 | 949 | 1,133 | 1,352 | 1,795 | 2,317 |
| Net Debt 1 | -5,846 | -5,180 | -7,069 | -5,747 | -6,268 | -4,673 | -3,656 | -2,857 |
| Reference price 2 | 310.71 | 148.00 | 116.10 | 76.09 | 92.93 | 164.13 | 164.13 | 164.13 |
| Nbr of stocks (in thousands) | 368,307 | 364,755 | 364,426 | 354,879 | 359,442 | 359,630 | - | - |
| Announcement Date | 3/30/22 | 3/30/23 | 3/28/24 | 3/28/25 | 3/30/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 31.96x | 11.62x | 23.56x | 0.62% | 1,001B | ||
| 29.63x | - | - | 2.02% | 642B | ||
| 32.65x | 7.56x | 15.72x | 2.69% | 451B | ||
| 18.78x | 4.58x | 11.35x | 2.9% | 340B | ||
| 19.52x | 5.11x | 12.66x | 3.19% | 263B | ||
| 20.44x | 4.2x | 12.01x | 2.1% | 247B | ||
| 24.19x | 6.38x | 11.35x | 2.64% | 207B | ||
| 12.74x | 4.63x | 9.67x | 3.94% | 197B | ||
| -43.8x | 6.4x | 24.98x | 2.27% | 180B | ||
| Average | 16.23x | 6.31x | 15.16x | 2.48% | 391.82B | |
| Weighted average by Cap. | 23.23x | 7.75x | 17.18x | 2.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 002821 Stock
- 6821 Stock
- Valuation Asymchem Laboratories (Tianjin) Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















